You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Patient characteristics

From: Intensity modulated radiotherapy for elderly bladder cancer patients

  IMRT HT All
  No. of patient (%)
Age (years)    
   Mean 79.9 78.5 79.2
   Range 66-90 65-89 65-90
Gender    
   Male 7 (77.8%) 7 (70%) 14 (73.7%)
   Female 2 (22.2%) 3 (30%) 5 (26.3%)
Karnofsky performance status    
   < 60 0 0 0
   ≥ 60 9 (100%) 10 (100%) 19 (100%)
Pathology    
   Urothelial carcinoma 9 (100%) 10 (100%) 19 (100%)
Tumor stage    
   Stage I 0 1 (10%) 1 (5.3%)
   Stage II 2 (22.2%) 2 (20%) 4 (21.1%)
   Stage III 4 (44.4%) 4 (40%) 8 (42.1%)
   Stage IV 3 (33.3%) 3 (30%) 6 (31.6%)
Primary Tumor stage    
   T1-high risk 0 1 (10%) 1 (5.3%)
   T2 2 (22.2%) 3 (30%) 5 (26.3%)
   T3 5 (55.6%) 3 (30%) 8 (42.1%)
   T4 2 (22.2%) 3 (30%) 5 (26.3%)
Regional Lymph Node stage    
   N0 6 (66.7%) 7 (70%) 13 (68.4%)
   N1 2 (22.2%) 1 (10%) 3 (15.8%)
   N2 1 (11.1%) 2 (20%) 3 (15.8%)
Concurrent with chemotherapy 3 (33.3%) 6 (60%) 9 (47.4%)
Median dose for RT completion (range) (Gy) 57.6 (45-64.8) 57.6 (54-64.8) 57.6 (45-64.8)
Median time for RT completion (range) (wks) 7 (6-11) 6.5 (5-10) 7 (5-11)
  1. Abbreviations:
  2. All = all Patients in the study; HT = helical tomotherapy; IMRT = intensity-modulated radiation therapy; RT = radiation therapy